Effects of Nonsteroidal Anti-Inflammatory Drugs on Flexor Tendon Adhesion

Journal of Hand Surgery

Volumn 35, Issue 6, 2010, Pages 941-947

  Tan, Virak ^a   Nourbakhsh, Ali ^a   Capo, John ^a   Cottrell, Jessica A ^a   Meyenhofer, Marcus ^a   O'Connor, J Patrick ^a  

^a RUTGERS NEW JERSEY MEDICAL SCHOOL   (United States)

Author keywords

adhesions; COX 2; Flexor tendon; NSAIDs; rabbit

Indexed keywords

CYCLOOXYGENASE 1; CYCLOOXYGENASE 2; IBUPROFEN; PLACEBO; ROFECOXIB; CYCLOOXYGENASE 2 INHIBITOR; LACTONE; NONSTEROID ANTIINFLAMMATORY AGENT; SULFONE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; FLEXOR DIGITORUM PROFUNDUS; FLEXOR TENDON ADHESION; FLEXOR TENDON INJURY; HISTOPATHOLOGY; IMMOBILIZATION; MALE; METACARPAL BONE; METACARPOPHALANGEAL JOINT; NONHUMAN; PHALANX; POSTOPERATIVE PERIOD; PRIORITY JOURNAL; RABBIT; RANGE OF MOTION; TENDON RECONSTRUCTION; TENDON SHEATH; TISSUE ADHESION; WEIGHT; ANIMAL; COMPARATIVE STUDY; DRUG EFFECTS; FORELIMB; SURGERY; TENDON; TISSUE ADHESIONS; WOUND HEALING;

ANIMALS; ANTI-INFLAMMATORY AGENTS, NON-STEROIDAL; CYCLOOXYGENASE 2 INHIBITORS; FORELIMB; IBUPROFEN; LACTONES; MALE; RABBITS; SULFONES; TENDONS; TISSUE ADHESIONS; WOUND HEALING;

EID: 77952738633     PISSN: 03635023     EISSN: 15316564     Source Type: Journal    
DOI: 10.1016/j.jhsa.2010.02.033     Document Type: Article

References (22)

1. Vane J.R., Bakhle Y.S., and Botting R.M. Cyclooxygenase 1 and 2. Annu Rev Pharmacol Toxicol 38 (1998) 97-120
2. Steinmeyer J. Pharmacological basis for the therapy of pain and inflammation with non-steroidal anti-inflammatory drugs. Arthritis Res 2 (2000) 379-385
3. Sinatra R. Role of COX-2 in the evolution of acute pain management. J Pain Symptom Manage 24 (2002) S18-S27
4. Mitchell J.A., Akarasereenont P., Thiemermann C., Flower R.J., and Vane J.R. Selectivity of nonsteroidal antiinflammatory drugs as inhibitors of constitutive and inducible cyclooxygenase. Proc Natl Acad Sci U S A 90 (1993) 11693-11697
5. Warner T.D., Giuliano F., Vojnovic I., Bukasa A., Mitchell J.A., and Vane J.R. Nonsteroid drug selectivities for cyclo-oxygenase-1 rather than cyclo-oxygenase-2 are associated with human gastrointestinal toxicity: a full in vitro analysis. Proc Natl Acad Sci U S A 96 (1999) 7563-7568
6. Penning T.D., Talley J.J., Bertenshaw S.R., Carter J.S., Collins P.W., Docter S., et al. Synthesis and biological evaluation of the 1,5-diarylpyrazole class of cyclooxygenase-2 inhibitors: identification of 4-[5-(4-methylphenyl)-3-(trifluoromethyl)-1H-pyrazol-1-yl]benzenesulfonamide (SC-58635, celecoxib). J Med Chem 40 (1997) 1347-1365
7. Chan C.-C., Boyce S., Brideau C., Charleson S., Cromlish W., Ethier D., et al. Rofecoxib [Vioxx, MK-0966; 4-(4′-methylsulfonylphenyl)-3-phenyl-2-(5H)-furanone]: a potent and orally active cyclooxygenase-2 inhibitor. Pharmacological and biochemical profiles. J Pharmacol Exp Ther 290 (1999) 551-560
8. Riendeau D., Percival M.D., Brideau C., Charleson S., Dube D., Ethier D., et al. Etoricoxib (MK-0663): preclinical profile and comparison with other agents that selectively inhibit cyclooxygenase-2. J Pharmacol Exp Ther 296 (2001) 558-566
9. Talley J.J., Brown D.L., Carter J.S., Graneto M.J., Koboldt C.M., Masferrer J.L., et al. 4-[5-Methyl-3-phenylisoxazol-4-yl]-benzenesulfonamide, valdecoxib: a potent and selective inhibitor of COX-2. J Med Chem 43 (2000) 775-777
10. Radi Z.A., and Khan N.K. Effects of cyclooxygenase inhibition on bone, tendon, and ligament healing. Inflamm Res 54 (2005) 358-366
11. Sharma P., and Maffulli N. Tendon injury and tendinopathy: healing and repair. J Bone Joint Surg 87A (2005) 187-202
12. Lin T.W., Cardenas L., and Soslowsky L.J. Biomechanics of tendon injury and repair. J Biomech 37 (2004) 865-877
13. Simon A.M., Manigrasso M.B., and O'Connor J.P. Cyclo-oxygenase 2 function is essential for bone fracture healing. Jf Bone Miner Res 17 (2002) 963-976
14. Simon A.M., and O'Connor J.P. Dose and time-dependent effects of cyclooxygenase-2 inhibition on fracture-healing. J Bone Joint Surg 89A (2007) 500-511
15. Gerstenfeld L.C., Al-Ghawas M., Alkhiary Y.M., Cullinane D.M., Krall E.A., Fitch J.L., et al. Selective and nonselective cyclooxygenase-2 inhibitors and experimental fracture-healing: reversibility of effects after short-term treatment. J Bone Joint Surg 89A (2007) 114-125
16. O'Connor J.P., Capo J.T., Tan V., Cottrell J.A., Manigrasso M.B., Bontempo N., et al. A comparison of the effects of ibuprofen and rofecoxib on rabbit fibula osteotomy healing. Acta Orthop 80 (2009) 597-605
17. Goodman S., Ma T., Trindade M., Ikenoue T., Matsuura I., Wong N., et al. COX-2 selective NSAID decreases bone ingrowth in vivo. J Orthop Res 20 (2002) 1164-1169
18. Kulick M.I., Smith S., and Hadler K. Oral ibuprofen: evaluation of its effect on peritendinous adhesions and the breaking strength of a tenorrhaphy. J Hand Surg 11A (1986) 110-120
19. Tang J.B., Cao Y., Wu Y.F., and Wang G.H. Effect of A2 pulley release on repaired tendon gliding resistance and rupture in a chicken model. J Hand Surg 34A (2009) 1080-1087
20. Tang J.B., Ishii S., Usui M., and Aoki M. Dorsal and circumferential sheath reconstructions for flexor sheath defect with concomitant bony injury. J Hand Surg 19A (1994) 61-69
21. Tang J.B., Shi D., and Zhang Q.G. Biomechanical and histologic evaluation of tendon sheath management. J Hand Surg 21A (1996) 900-908
22. Tang J.B. Clinical outcomes associated with flexor tendon repair. Hand Clin 21 (2005) 199-210